Consensus practice recommendations for management of gastrointestinal dysfunction in Parkinson disease

被引:2
作者
Safarpour, Delaram [1 ]
Stover, Natividad [2 ]
Shprecher, David R. [3 ]
Hamedani, Ali G. [4 ]
Pfeiffer, Ronald F. [1 ]
Parkman, Henry P. [5 ]
Quigley, Eamonn M. M. [6 ,7 ]
Cloud, Leslie J. [8 ]
机构
[1] Oregon Hlth & Sci Univ, Sch Med, Dept Neurol, Portland, OR USA
[2] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL USA
[3] Banner Sun Hlth Res Inst, Sun City, AZ USA
[4] Univ Penn, Perelman Sch Med, Dept Neurol Ophthalmol & Epidemiol, Philadelphia, PA USA
[5] Temple Univ, Sch Med, Dept Med, Sect Gastroenterol, Philadelphia, PA USA
[6] Houston Methodist Hosp, Lynda K & David M Underwood Ctr Digest Disorders, Houston, TX USA
[7] Weill Cornell Med Coll, Houston, TX USA
[8] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA USA
关键词
Parkinson 's disease; Parkinson disease; Gastrointestinal dysfunction; Constipation; Gastric emptying delay; Small intestinal bacterial overgrowth; Swallowing dysfunction; Drooling; Consensus recommendation; INTESTINAL BACTERIAL OVERGROWTH; PLACEBO-CONTROLLED TRIAL; IRRITABLE-BOWEL-SYNDROME; BIOFEEDBACK THERAPY; CHRONIC CONSTIPATION; DOUBLE-BLIND; SIALORRHEA; PRUCALOPRIDE; MODULATION; PROBIOTICS;
D O I
10.1016/j.parkreldis.2024.106982
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Gastrointestinal (GI) dysfunction is a common non-motor feature of Parkinson disease (PD). GI symptoms may start years before the onset of motor symptoms and impair quality of life. Robust clinical trial data is lacking to guide screening, diagnosis and treatment of GI dysfunction in PD. Objective: To develop consensus statements on screening, diagnosis, and treatment of GI dysfunction in PD. Methods: The application of a modified Delphi panel allowed for the synthesis of expert opinions into clinical statements. Consensus was predefined as a level of agreement of 100 % for each item. Five virtual Delphi rounds were held. Two movement disorders neurologists reviewed the literature on GI dysfunction in PD and developed draft statements based on the literature review. Draft statements were distributed among the panel that included five movement disorder neurologists and two gastroenterologists, both experts in GI dysmotility and its impact on PD symptoms. All members reviewed the statements and references in advance of the virtual meetings. In the virtual meetings, each statement was discussed, edited, and a vote was conducted. If there was not 100 % consensus, further discussions and modifications ensued until there was consensus. Results: Statements were developed for screening, diagnosis, and treatment of common GI symptoms in PD and were organized by anatomic segments: oral cavity and esophagus, stomach, small intestine, and colon and anorectum. Conclusions: These consensus recommendations offer a practical framework for the diagnosis and treatment of GI dysfunction in PD.
引用
收藏
页数:7
相关论文
共 73 条
  • [1] Bristol Stool Chart: Prospective and monocentric study of "stools introspection" in healthy subjects
    Amarenco, G.
    [J]. PROGRES EN UROLOGIE, 2014, 24 (11): : 708 - 713
  • [2] Glycopyrrolate for sialorrhea in Parkinson disease A randomized, double-blind, crossover trial
    Arbouw, M. E. L.
    Movig, K. L. L.
    Koopmann, M.
    Poels, P. J. E.
    Guchelaar, H. -J.
    Egberts, T. C. G.
    Neef, C.
    van Vugt, J. P. P.
    [J]. NEUROLOGY, 2010, 74 (15) : 1203 - 1207
  • [3] The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson's disease
    Barboza, Jose L.
    Okun, Michael S.
    Moshiree, Baharak
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (16) : 2449 - 2464
  • [4] Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson's Disease - The RESISTA-PD Trial
    Becker, Anouck
    Schmartz, Georges Pierre
    Groeger, Laura
    Grammes, Nadja
    Galata, Valentina
    Philippeit, Hannah
    Weiland, Jacqueline
    Ludwig, Nicole
    Meese, Eckart
    Tierling, Sascha
    Walter, Jorn
    Schwiertz, Andreas
    Spiegel, Jorg
    Wagenpfeil, Gudrun
    Fassbender, Klaus
    Keller, Andreas
    Unger, Marcus M.
    [J]. GENOMICS PROTEOMICS & BIOINFORMATICS, 2022, 20 (02) : 274 - 287
  • [5] MDS research criteria for prodromal Parkinson's disease
    Berg, Daniela
    Postuma, Ronald B.
    Adler, Charles H.
    Bloem, Bastiaan R.
    Chan, Piu
    Dubois, Bruno
    Gasser, Thomas
    Goetz, Christopher G.
    Halliday, Glenda
    Joseph, Lawrence
    Lang, Anthony E.
    Liepelt-Scarfone, Inga
    Litvan, Irene
    Marek, Kenneth
    Obeso, Jose
    Oertel, Wolfgang
    Olanow, C. Warren
    Poewe, Werner
    Stern, Matthew
    Deuschl, Guenther
    [J]. MOVEMENT DISORDERS, 2015, 30 (12) : 1600 - 1609
  • [6] Comparison of Anorectal Manometry, Rectal Balloon Expulsion Test, and Defecography for Diagnosing Defecatory Disorders
    Blackett, John W.
    Gautam, Misha
    Mishra, Rahul
    Oblizajek, Nicholas R.
    Ramu, Shivabalan Kathavarayan
    Bailey, Kent R.
    Bharucha, Adil E.
    [J]. GASTROENTEROLOGY, 2022, 163 (06) : 1582 - +
  • [7] Rectal balloon training as add-on therapy to pelvic floor muscle training in adults with fecal incontinence: A randomized controlled trial
    Bols, Esther
    Berghmans, Bary
    de Bie, Rob
    Govaert, Bas
    van Wunnik, Bart
    Heymans, Martijn
    Hendriks, Erik
    Baeten, Cor
    [J]. NEUROUROLOGY AND URODYNAMICS, 2012, 31 (01) : 132 - 138
  • [8] Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder
    Bouras, EP
    Camilleri, M
    Burton, DD
    Thomforde, G
    McKinzie, S
    Zinsmeister, AR
    [J]. GASTROENTEROLOGY, 2001, 120 (02) : 354 - 360
  • [9] Chronic Constipation in the Elderly
    Bouras, Ernest P.
    Tangalos, Eric G.
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2009, 38 (03) : 463 - +
  • [10] An Adaptation of the RAND/UCLA Modified Delphi Panel Method in the Time of COVID-19
    Broder, Michael S.
    Gibbs, Sarah N.
    Yermilov, Irina
    [J]. JOURNAL OF HEALTHCARE LEADERSHIP, 2022, 14 : 63 - 70